Shivalik Rasayan Ltd.

SHIVALIK

₹555.0

1.66% (9.05)

Market Cap

₹850 Cr.

P/E

71.35

About

Shivalik Rasayan Ltd. (SRL), established in 1981, is a manufacturer of organophosphorous based insecticides and chemicals. SRL today produces international quality Malathion Technical and Dimethoate T… Read more

Shivalik Rasayan Ltd. (SRL), established in 1981, is a manufacturer of organophosphorous based… Read more

Low

498

52W Range

High

777

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

5 Yes

Positive for this company

3 Neutral

Neutral for this company

8 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

Capacity Utilization - Dimethoate (%)
Source
Realization/Tonne - Dimethoate (Rs/MT)
Source
Realization/Tonne - Sodium hydrosulfide (Rs/MT)
Source

Peer Comparison

FAQs on Shivalik Rasayan Ltd. Business

What does Shivalik Rasayan do?

Established in 1981, Shivalik Rasayan Ltd. (SRL) is a leading manufacturer of international quality Malathion Technical and Dimethoate Technical, well established in Indian and foreign markets.

Who are the competitors of Shivalik Rasayan?

Shivalik Rasayan major competitors are Albert David, Ind-Swift Lab., Kwality Pharma, Wanbury, Sakar Healthcare, Prevest Denpro, Gennex Lab.
Market Cap of Shivalik Rasayan is ₹850 Crs.
While the median market cap of its peers are ₹800 Crs.

Is Shivalik Rasayan financially stable compared to its competitors?

Shivalik Rasayan seems to be less financially stable compared to its competitors.
Altman Z score of Shivalik Rasayan is 5637114.74 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Jun Sep Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Jun Sep Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Jun Sep Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun Sep Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec